Explore more publications!
Health Update Bahamas
Got News to Share?

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 15, 2025

MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
December 15, 2025

MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13

Indeterminate GlobeNewswire
Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12
December 15, 2025

Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12

Indeterminate GlobeNewswire
Dentsply Sirona Declares Quarterly Cash Dividend
December 15, 2025

Dentsply Sirona Declares Quarterly Cash Dividend

Indeterminate GlobeNewswire
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor Functional Beverage Distribution with Three New Direct Store Delivery Partners Across Maine and Pennsylvania
December 15, 2025

Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor Functional Beverage Distribution with Three New Direct Store Delivery Partners Across Maine and Pennsylvania

Indeterminate GlobeNewswire
NeuroSigma Completes $1 Million Investment into High-Volume Manufacturing Line for Second Generation Monarch eTNS® Device
December 15, 2025

NeuroSigma Completes $1 Million Investment into High-Volume Manufacturing Line for Second Generation Monarch eTNS® Device

Indeterminate GlobeNewswire
Euromonitor International Names Synergy Pro-Argi-9+ the World’s #1 L-Arginine Supplement
December 15, 2025

Euromonitor International Names Synergy Pro-Argi-9+ the World’s #1 L-Arginine Supplement

Indeterminate GlobeNewswire
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
December 15, 2025

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission

Indeterminate GlobeNewswire
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
December 15, 2025

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

Indeterminate GlobeNewswire
Big Nova Gives $3 Million to Advance NMDP’s Mission and Help More Patients Receive Blood Stem Cell Transplants
December 15, 2025

Big Nova Gives $3 Million to Advance NMDP’s Mission and Help More Patients Receive Blood Stem Cell Transplants

Indeterminate GlobeNewswire
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 15, 2025

FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
December 15, 2025

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Indeterminate GlobeNewswire
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025
December 15, 2025

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Indeterminate GlobeNewswire
3D Systems Announces FDA 510(k) Clearance Expanding VSP Orthopedics Indications to Include Skeletally Mature Adolescents
December 15, 2025

3D Systems Announces FDA 510(k) Clearance Expanding VSP Orthopedics Indications to Include Skeletally Mature Adolescents

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering
December 15, 2025

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

Indeterminate GlobeNewswire
Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results
December 15, 2025

Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Indeterminate GlobeNewswire
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
December 15, 2025

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

Indeterminate GlobeNewswire
Claire’s Place Foundation Steps Up for Cystic Fibrosis Community in a Year Marked by Wildfires & Rising Costs
December 15, 2025

Claire’s Place Foundation Steps Up for Cystic Fibrosis Community in a Year Marked by Wildfires & Rising Costs

Indeterminate GlobeNewswire
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
December 15, 2025

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins

Indeterminate GlobeNewswire
Zenas BioPharma’s Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus
December 15, 2025

Zenas BioPharma’s Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus

Indeterminate GlobeNewswire
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions